<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-05-30" modified="2017-10-25" version="175">
<accession>O43426</accession>
<accession>O43425</accession>
<accession>O94984</accession>
<accession>Q4KMR1</accession>
<name>SYNJ1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Synaptojanin-1</fullName>
<ecNumber>3.1.3.36</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SYNJ1</name>
<name type="synonym">KIAA0910</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="FEBS Lett." volume="419" first="175" last="180">
<title>Synaptojanin 1: localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15.</title>
<authorList>
<person name="Haffner C."/>
<person name="Takei K."/>
<person name="Chen H."/>
<person name="Ringstad N."/>
<person name="Hudson A."/>
<person name="Butler M.H."/>
<person name="Salcini A.E."/>
<person name="Di Fiore P.P."/>
<person name="De Camilli P."/>
</authorList>
<dbReference type="PubMed" id="9428629"/>
<dbReference type="DOI" id="10.1016/S0014-5793(97)01451-8"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANT ARG-295</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="DNA Res." volume="5" first="355" last="364">
<title>Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Suyama M."/>
<person name="Kikuno R."/>
<person name="Hirosawa M."/>
<person name="Miyajima N."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10048485"/>
<dbReference type="DOI" id="10.1093/dnares/5.6.355"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2002" name="DNA Res." volume="9" first="99" last="106">
<title>Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.</title>
<authorList>
<person name="Nakajima D."/>
<person name="Okazaki N."/>
<person name="Yamakawa H."/>
<person name="Kikuno R."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
</authorList>
<dbReference type="PubMed" id="12168954"/>
<dbReference type="DOI" id="10.1093/dnares/9.3.99"/>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="Nature" volume="405" first="311" last="319">
<title>The DNA sequence of human chromosome 21.</title>
<authorList>
<person name="Hattori M."/>
<person name="Fujiyama A."/>
<person name="Taylor T.D."/>
<person name="Watanabe H."/>
<person name="Yada T."/>
<person name="Park H.-S."/>
<person name="Toyoda A."/>
<person name="Ishii K."/>
<person name="Totoki Y."/>
<person name="Choi D.-K."/>
<person name="Groner Y."/>
<person name="Soeda E."/>
<person name="Ohki M."/>
<person name="Takagi T."/>
<person name="Sakaki Y."/>
<person name="Taudien S."/>
<person name="Blechschmidt K."/>
<person name="Polley A."/>
<person name="Menzel U."/>
<person name="Delabar J."/>
<person name="Kumpf K."/>
<person name="Lehmann R."/>
<person name="Patterson D."/>
<person name="Reichwald K."/>
<person name="Rump A."/>
<person name="Schillhabel M."/>
<person name="Schudy A."/>
<person name="Zimmermann W."/>
<person name="Rosenthal A."/>
<person name="Kudoh J."/>
<person name="Shibuya K."/>
<person name="Kawasaki K."/>
<person name="Asakawa S."/>
<person name="Shintani A."/>
<person name="Sasaki T."/>
<person name="Nagamine K."/>
<person name="Mitsuyama S."/>
<person name="Antonarakis S.E."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
<person name="Nordsiek G."/>
<person name="Hornischer K."/>
<person name="Brandt P."/>
<person name="Scharfe M."/>
<person name="Schoen O."/>
<person name="Desario A."/>
<person name="Reichelt J."/>
<person name="Kauer G."/>
<person name="Bloecker H."/>
<person name="Ramser J."/>
<person name="Beck A."/>
<person name="Klages S."/>
<person name="Hennig S."/>
<person name="Riesselmann L."/>
<person name="Dagand E."/>
<person name="Wehrmeyer S."/>
<person name="Borzym K."/>
<person name="Gardiner K."/>
<person name="Nizetic D."/>
<person name="Francis F."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Yaspo M.-L."/>
</authorList>
<dbReference type="PubMed" id="10830953"/>
<dbReference type="DOI" id="10.1038/35012518"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="32001" last="32007">
<title>The SH3 domains of endophilin and amphiphysin bind to the proline-rich region of synaptojanin 1 at distinct sites that display an unconventional binding specificity.</title>
<authorList>
<person name="Cestra G."/>
<person name="Castagnoli L."/>
<person name="Dente L."/>
<person name="Minenkova O."/>
<person name="Petrelli A."/>
<person name="Migone N."/>
<person name="Hoffmueller U."/>
<person name="Schneider-Mergener J."/>
<person name="Cesareni G."/>
</authorList>
<dbReference type="PubMed" id="10542231"/>
<dbReference type="DOI" id="10.1074/jbc.274.45.32001"/>
</citation>
<scope>INTERACTION WITH AMPH; SH3GL1; SH3GL2 AND SH3GL3</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2007" name="FEBS Lett." volume="581" first="644" last="650">
<title>Myosin 1E interacts with synaptojanin-1 and dynamin and is involved in endocytosis.</title>
<authorList>
<person name="Krendel M."/>
<person name="Osterweil E.K."/>
<person name="Mooseker M.S."/>
</authorList>
<dbReference type="PubMed" id="17257598"/>
<dbReference type="DOI" id="10.1016/j.febslet.2007.01.021"/>
</citation>
<scope>INTERACTION WITH MYO1E</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-830; THR-1220; SER-1551 AND SER-1565</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-830</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1318</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-830; THR-1220; SER-1292; SER-1345 AND SER-1565</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1220</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2016" name="Brain" volume="139" first="2420" last="2430">
<title>Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline.</title>
<authorList>
<consortium name="AR working group of the EuroEPINOMICS RES Consortium"/>
<person name="Hardies K."/>
<person name="Cai Y."/>
<person name="Jardel C."/>
<person name="Jansen A.C."/>
<person name="Cao M."/>
<person name="May P."/>
<person name="Djemie T."/>
<person name="Hachon Le Camus C."/>
<person name="Keymolen K."/>
<person name="Deconinck T."/>
<person name="Bhambhani V."/>
<person name="Long C."/>
<person name="Sajan S.A."/>
<person name="Helbig K.L."/>
<person name="Suls A."/>
<person name="Balling R."/>
<person name="Helbig I."/>
<person name="De Jonghe P."/>
<person name="Depienne C."/>
<person name="De Camilli P."/>
<person name="Weckhuysen S."/>
</authorList>
<dbReference type="PubMed" id="27435091"/>
<dbReference type="DOI" id="10.1093/brain/aww180"/>
</citation>
<scope>FUNCTION</scope>
<scope>INVOLVEMENT IN EIEE53</scope>
<scope>VARIANT EIEE53 CYS-849</scope>
<scope>CHARACTERIZATION OF VARIANT EIEE53 CYS-849</scope>
<scope>VARIANTS ILE-981 AND SER-1018</scope>
<scope>CHARACTERIZATION OF VARIANTS ILE-981 AND SER-1018</scope>
</reference>
<reference key="14">
<citation type="submission" date="2006-10" db="PDB data bank">
<title>Solution structure of RNA binding domain in synaptojanin 1.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 894-971</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2013" name="Hum. Mutat." volume="34" first="1200" last="1207">
<title>The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures.</title>
<authorList>
<person name="Krebs C.E."/>
<person name="Karkheiran S."/>
<person name="Powell J.C."/>
<person name="Cao M."/>
<person name="Makarov V."/>
<person name="Darvish H."/>
<person name="Di Paolo G."/>
<person name="Walker R.H."/>
<person name="Shahidi G.A."/>
<person name="Buxbaum J.D."/>
<person name="De Camilli P."/>
<person name="Yue Z."/>
<person name="Paisan-Ruiz C."/>
</authorList>
<dbReference type="PubMed" id="23804563"/>
<dbReference type="DOI" id="10.1002/humu.22372"/>
</citation>
<scope>VARIANT PARK20 GLN-219</scope>
<scope>CHARACTERIZATION OF VARIANT PARK20 GLN-219</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2013" name="Hum. Mutat." volume="34" first="1208" last="1215">
<title>Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism.</title>
<authorList>
<person name="Quadri M."/>
<person name="Fang M."/>
<person name="Picillo M."/>
<person name="Olgiati S."/>
<person name="Breedveld G.J."/>
<person name="Graafland J."/>
<person name="Wu B."/>
<person name="Xu F."/>
<person name="Erro R."/>
<person name="Amboni M."/>
<person name="Pappata S."/>
<person name="Quarantelli M."/>
<person name="Annesi G."/>
<person name="Quattrone A."/>
<person name="Chien H.F."/>
<person name="Barbosa E.R."/>
<person name="Oostra B.A."/>
<person name="Barone P."/>
<person name="Wang J."/>
<person name="Bonifati V."/>
</authorList>
<dbReference type="PubMed" id="23804577"/>
<dbReference type="DOI" id="10.1002/humu.22373"/>
</citation>
<scope>VARIANTS PARK20 GLN-219 AND ARG-1383</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2016" name="Parkinsonism Relat. Disord." volume="31" first="124" last="128">
<title>Identification of a novel homozygous mutation Arg459Pro in SYNJ1 gene of an Indian family with autosomal recessive juvenile Parkinsonism.</title>
<authorList>
<person name="Kirola L."/>
<person name="Behari M."/>
<person name="Shishir C."/>
<person name="Thelma B.K."/>
</authorList>
<dbReference type="PubMed" id="27496670"/>
<dbReference type="DOI" id="10.1016/j.parkreldis.2016.07.014"/>
</citation>
<scope>VARIANT PARK20 PRO-420</scope>
</reference>
<comment type="function">
<text evidence="8 9 18">Phosphatase that acts on various phosphoinositides, including phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate (PubMed:27435091). Has a role in clathrin-mediated endocytosis (By similarity). Hydrolyzes PIP2 bound to actin regulatory proteins resulting in the rearrangement of actin filaments downstream of tyrosine kinase and ASH/GRB2 (By similarity).</text>
</comment>
<comment type="catalytic activity">
<text>1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H(2)O = 1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate.</text>
</comment>
<comment type="subunit">
<text evidence="7 14 15">Interacts with ASH/GRB2. Interacts with PACSIN1, PACSIN2 and PACSIN3 (By similarity). Binds AMPH, SH3GL1, SH3GL2 and SH3GL3. Interacts with MYO1E (via SH3 domain).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Cytoplasm</location>
<location evidence="8">perinuclear region</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O43426-1</id>
<name>1</name>
<name>Synaptojanin-170</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O43426-2</id>
<name>2</name>
<name>Synaptojanin-145</name>
<sequence type="described" ref="VSP_002682 VSP_002683"/>
</isoform>
<isoform>
<id>O43426-4</id>
<name>3</name>
<sequence type="described" ref="VSP_041578 VSP_002682 VSP_002683"/>
</isoform>
<isoform>
<id>O43426-5</id>
<name>4</name>
<sequence type="described" ref="VSP_035709 VSP_035710 VSP_035711"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Concentrated at clathrin-coated endocytic intermediates in nerve terminals. Isoform 1 is more enriched than isoform 2 in developing brain as well as non-neuronal cells. Isoform 2 is very abundant in nerve terminals.</text>
</comment>
<comment type="domain">
<text evidence="7">Binds to EPS15 (a clathrin coat-associated protein) via a C-terminal domain containing three Asn-Pro-Phe (NPF) repeats.</text>
</comment>
<comment type="domain">
<text>The C-terminal proline-rich region mediates binding to a variety of SH3 domain-containing proteins including AMPH, SH3GL1, SH3GL2, SH3GL3 and GRB2.</text>
</comment>
<comment type="disease" evidence="16 17 19">
<disease id="DI-03964">
<name>Parkinson disease 20, early-onset</name>
<acronym>PARK20</acronym>
<description>An early-onset form of Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. PARK20 is characterized by young adult-onset of parkinsonism. Additional features may include seizures, cognitive decline, abnormal eye movements, and dystonia.</description>
<dbReference type="MIM" id="615530"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="18">
<disease id="DI-04961">
<name>Epileptic encephalopathy, early infantile, 53</name>
<acronym>EIEE53</acronym>
<description>A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE53 inheritance is autosomal recessive.</description>
<dbReference type="MIM" id="617389"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="24">Belongs to the synaptojanin family.</text>
</comment>
<comment type="similarity">
<text evidence="24">In the central section; belongs to the inositol 1,4,5-trisphosphate 5-phosphatase family.</text>
</comment>
<comment type="sequence caution" evidence="24">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA74933" version="2"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<dbReference type="EC" id="3.1.3.36"/>
<dbReference type="EMBL" id="AF009039">
<property type="protein sequence ID" value="AAC51921.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF009040">
<property type="protein sequence ID" value="AAC51922.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB020717">
<property type="protein sequence ID" value="BAA74933.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000275">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000276">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000277">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000278">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000279">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC098395">
<property type="protein sequence ID" value="AAH98395.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54483.1">
<molecule id="O43426-4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001153774.1">
<molecule id="O43426-4"/>
<property type="nucleotide sequence ID" value="NM_001160302.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001153778.1">
<property type="nucleotide sequence ID" value="NM_001160306.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003886.3">
<property type="nucleotide sequence ID" value="NM_003895.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_982271.2">
<property type="nucleotide sequence ID" value="NM_203446.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016883989.1">
<molecule id="O43426-2"/>
<property type="nucleotide sequence ID" value="XM_017028500.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.473632"/>
<dbReference type="PDB" id="1W80">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="P=1477-1488, Q=1458-1469"/>
</dbReference>
<dbReference type="PDB" id="2DNR">
<property type="method" value="NMR"/>
<property type="chains" value="A=894-971"/>
</dbReference>
<dbReference type="PDB" id="2VJ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="P=1477-1488"/>
</dbReference>
<dbReference type="PDBsum" id="1W80"/>
<dbReference type="PDBsum" id="2DNR"/>
<dbReference type="PDBsum" id="2VJ0"/>
<dbReference type="ProteinModelPortal" id="O43426"/>
<dbReference type="SMR" id="O43426"/>
<dbReference type="BioGrid" id="114388">
<property type="interactions" value="18"/>
</dbReference>
<dbReference type="ELM" id="O43426"/>
<dbReference type="IntAct" id="O43426">
<property type="interactions" value="8"/>
</dbReference>
<dbReference type="MINT" id="MINT-109209"/>
<dbReference type="STRING" id="9606.ENSP00000409667"/>
<dbReference type="DEPOD" id="O43426"/>
<dbReference type="iPTMnet" id="O43426"/>
<dbReference type="PhosphoSitePlus" id="O43426"/>
<dbReference type="BioMuta" id="SYNJ1"/>
<dbReference type="EPD" id="O43426"/>
<dbReference type="MaxQB" id="O43426"/>
<dbReference type="PaxDb" id="O43426"/>
<dbReference type="PeptideAtlas" id="O43426"/>
<dbReference type="PRIDE" id="O43426"/>
<dbReference type="Ensembl" id="ENST00000357345">
<molecule id="O43426-4"/>
<property type="protein sequence ID" value="ENSP00000349903"/>
<property type="gene ID" value="ENSG00000159082"/>
</dbReference>
<dbReference type="GeneID" id="8867"/>
<dbReference type="KEGG" id="hsa:8867"/>
<dbReference type="UCSC" id="uc002yqf.2">
<molecule id="O43426-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8867"/>
<dbReference type="DisGeNET" id="8867"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000159082.17"/>
<dbReference type="GeneCards" id="SYNJ1"/>
<dbReference type="HGNC" id="HGNC:11503">
<property type="gene designation" value="SYNJ1"/>
</dbReference>
<dbReference type="HPA" id="HPA011916"/>
<dbReference type="MalaCards" id="SYNJ1"/>
<dbReference type="MIM" id="604297">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615530">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="617389">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O43426"/>
<dbReference type="OpenTargets" id="ENSG00000159082"/>
<dbReference type="Orphanet" id="391411">
<property type="disease" value="Atypical juvenile parkinsonism"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36285"/>
<dbReference type="eggNOG" id="KOG0566">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5329">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="eggNOG" id="COG5411">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119075"/>
<dbReference type="HOGENOM" id="HOG000007937"/>
<dbReference type="HOVERGEN" id="HBG079225"/>
<dbReference type="InParanoid" id="O43426"/>
<dbReference type="KO" id="K20279"/>
<dbReference type="PhylomeDB" id="O43426"/>
<dbReference type="BioCyc" id="MetaCyc:HS08354-MONOMER"/>
<dbReference type="Reactome" id="R-HSA-1660499">
<property type="pathway name" value="Synthesis of PIPs at the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1855183">
<property type="pathway name" value="Synthesis of IP2, IP, and Ins in the cytosol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1855204">
<property type="pathway name" value="Synthesis of IP3 and IP4 in the cytosol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="SIGNOR" id="O43426"/>
<dbReference type="ChiTaRS" id="SYNJ1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O43426"/>
<dbReference type="GenomeRNAi" id="8867"/>
<dbReference type="PRO" id="PR:O43426"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 21"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000159082"/>
<dbReference type="CleanEx" id="HS_SYNJ1"/>
<dbReference type="ExpressionAtlas" id="O43426">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O43426">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030132">
<property type="term" value="C:clathrin coat of coated pit"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030117">
<property type="term" value="C:membrane coat"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098793">
<property type="term" value="C:presynapse"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097060">
<property type="term" value="C:synaptic membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043195">
<property type="term" value="C:terminal bouton"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0012506">
<property type="term" value="C:vesicle membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0052659">
<property type="term" value="F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0052658">
<property type="term" value="F:inositol-1,4,5-trisphosphate 5-phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034596">
<property type="term" value="F:phosphatidylinositol phosphate 4-phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034595">
<property type="term" value="F:phosphatidylinositol phosphate 5-phosphatase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0052629">
<property type="term" value="F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043813">
<property type="term" value="F:phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004438">
<property type="term" value="F:phosphatidylinositol-3-phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004439">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043812">
<property type="term" value="F:phosphatidylinositol-4-phosphate phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0046855">
<property type="term" value="P:inositol phosphate dephosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043647">
<property type="term" value="P:inositol phosphate metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007612">
<property type="term" value="P:learning"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006836">
<property type="term" value="P:neurotransmitter transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006661">
<property type="term" value="P:phosphatidylinositol biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046856">
<property type="term" value="P:phosphatidylinositol dephosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046488">
<property type="term" value="P:phosphatidylinositol metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904980">
<property type="term" value="P:positive regulation of endosome organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048488">
<property type="term" value="P:synaptic vesicle endocytosis"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016082">
<property type="term" value="P:synaptic vesicle priming"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048489">
<property type="term" value="P:synaptic vesicle transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016191">
<property type="term" value="P:synaptic vesicle uncoating"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd12719">
<property type="entry name" value="RRM_SYNJ1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.60.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR015047">
<property type="entry name" value="DUF1866"/>
</dbReference>
<dbReference type="InterPro" id="IPR036691">
<property type="entry name" value="Endo/exonu/phosph_ase_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR005135">
<property type="entry name" value="Endo/exonuclease/phosphatase"/>
</dbReference>
<dbReference type="InterPro" id="IPR000300">
<property type="entry name" value="IPPc"/>
</dbReference>
<dbReference type="InterPro" id="IPR035979">
<property type="entry name" value="RBD_domain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000504">
<property type="entry name" value="RRM_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002013">
<property type="entry name" value="SAC_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR034972">
<property type="entry name" value="SYNJ1"/>
</dbReference>
<dbReference type="InterPro" id="IPR034971">
<property type="entry name" value="SYNJ1_RRM"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11200:SF158">
<property type="entry name" value="PTHR11200:SF158"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08952">
<property type="entry name" value="DUF1866"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03372">
<property type="entry name" value="Exo_endo_phos"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02383">
<property type="entry name" value="Syja_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01165">
<property type="entry name" value="DUF1866"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00128">
<property type="entry name" value="IPPc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54928">
<property type="entry name" value="SSF54928"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56219">
<property type="entry name" value="SSF56219"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50102">
<property type="entry name" value="RRM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50275">
<property type="entry name" value="SAC"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0254">Endocytosis</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0907">Parkinson disease</keyword>
<keyword id="KW-0908">Parkinsonism</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<feature type="chain" description="Synaptojanin-1" id="PRO_0000209730">
<location>
<begin position="1"/>
<end position="1573"/>
</location>
</feature>
<feature type="domain" description="SAC" evidence="13">
<location>
<begin position="119"/>
<end position="442"/>
</location>
</feature>
<feature type="domain" description="RRM" evidence="12">
<location>
<begin position="902"/>
<end position="971"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="1396"/>
<end position="1398"/>
</location>
</feature>
<feature type="repeat" description="2">
<location>
<begin position="1406"/>
<end position="1408"/>
</location>
</feature>
<feature type="repeat" description="3">
<location>
<begin position="1417"/>
<end position="1419"/>
</location>
</feature>
<feature type="region of interest" description="Catalytic" evidence="11">
<location>
<begin position="500"/>
<end position="899"/>
</location>
</feature>
<feature type="region of interest" description="3 X 3 AA repeats of N-P-F">
<location>
<begin position="1396"/>
<end position="1419"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="900"/>
<end position="1573"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="1033"/>
<end position="1036"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="1108"/>
<end position="1113"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="1126"/>
<end position="1129"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1485"/>
<end position="1488"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="1538"/>
<end position="1544"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="820"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 5">
<location>
<position position="830"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1053"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1150"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="1178"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="10">
<location>
<position position="1201"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2 5 6">
<location>
<position position="1220"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="1292"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="1318"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="1345"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="1349"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="1551"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5">
<location>
<position position="1565"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_035709" evidence="22">
<original>K</original>
<variation>KAGK</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_035710" evidence="22">
<location>
<begin position="504"/>
<end position="511"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_035711" evidence="22">
<location>
<begin position="525"/>
<end position="1573"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041578" evidence="21">
<location>
<begin position="1144"/>
<end position="1159"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_002682" evidence="21 23">
<original>VKTNGI</original>
<variation>QEQPSG</variation>
<location>
<begin position="1306"/>
<end position="1311"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_002683" evidence="21 23">
<location>
<begin position="1312"/>
<end position="1573"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK20; impairs the phosphatase activity of the enzyme toward phosphatidylinositol-3-phosphate and phosphatidylinositol-4-phosphate." id="VAR_070905" evidence="16 17">
<original>R</original>
<variation>Q</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2254562." id="VAR_047308" evidence="20">
<original>K</original>
<variation>R</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK20." id="VAR_078803" evidence="19">
<original>R</original>
<variation>P</variation>
<location>
<position position="420"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE53; decreased inositol phosphate phosphatase activity." id="VAR_078804" evidence="18">
<original>Y</original>
<variation>C</variation>
<location>
<position position="849"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; no effect on inositol phosphate phosphatase activity." id="VAR_078805" evidence="18">
<original>M</original>
<variation>I</variation>
<location>
<position position="981"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; no effect on inositol phosphate phosphatase activity." id="VAR_078806" evidence="18">
<original>Y</original>
<variation>S</variation>
<location>
<position position="1018"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9980589." id="VAR_047309">
<original>V</original>
<variation>A</variation>
<location>
<position position="1366"/>
</location>
</feature>
<feature type="sequence variant" description="In PARK20; unknown pathological significance; the patient also carries a heterozygous PINK1 truncating mutation." id="VAR_070906" evidence="17">
<original>S</original>
<variation>R</variation>
<location>
<position position="1383"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230767." id="VAR_049603">
<original>P</original>
<variation>L</variation>
<location>
<position position="1547"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA74933." ref="1" evidence="24">
<location>
<begin position="1093"/>
<end position="1108"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC51922." ref="1" evidence="24">
<original>V</original>
<variation>VNT</variation>
<location>
<position position="1366"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="895"/>
<end position="901"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="905"/>
<end position="907"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="912"/>
<end position="923"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="928"/>
<end position="933"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="935"/>
<end position="944"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="945"/>
<end position="950"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="951"/>
<end position="954"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="962"/>
<end position="968"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DNR"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O18964"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62910"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8CHC4"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00176"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00183"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10542231"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17257598"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23804563"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23804577"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27435091"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27496670"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9428629"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10048485"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9428629"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<sequence length="1573" mass="173103" checksum="D50B249B1EBFFC18" modified="2008-11-25" version="2">
MAFSKGFRIYHKLDPPPFSLIVETRHKEECLMFESGAVAVLSSAEKEAIKGTYSKVLDAY
GLLGVLRLNLGDTMLHYLVLVTGCMSVGKIQESEVFRVTSTEFISLRIDSSDEDRISEVR
KVLNSGNFYFAWSASGISLDLSLNAHRSMQEQTTDNRFFWNQSLHLHLKHYGVNCDDWLL
RLMCGGVEIRTIYAAHKQAKACLISRLSCERAGTRFNVRGTNDDGHVANFVETEQVVYLD
DSVSSFIQIRGSVPLFWEQPGLQVGSHRVRMSRGFEANAPAFDRHFRTLKNLYGKQIIVN
LLGSKEGEHMLSKAFQSHLKASEHAADIQMVNFDYHQMVKGGKAEKLHSVLKPQVQKFLD
YGFFYFNGSEVQRCQSGTVRTNCLDCLDRTNSVQAFLGLEMLAKQLEALGLAEKPQLVTR
FQEVFRSMWSVNGDSISKIYAGTGALEGKAKLKDGARSVTRTIQNNFFDSSKQEAIDVLL
LGNTLNSDLADKARALLTTGSLRVSEQTLQSASSKVLKSMCENFYKYSKPKKIRVCVGTW
NVNGGKQFRSIAFKNQTLTDWLLDAPKLAGIQEFQDKRSKPTDIFAIGFEEMVELNAGNI
VSASTTNQKLWAVELQKTISRDNKYVLLASEQLVGVCLFVFIRPQHAPFIRDVAVDTVKT
GMGGATGNKGAVAIRMLFHTTSLCFVCSHFAAGQSQVKERNEDFIEIARKLSFPMGRMLF
SHDYVFWCGDFNYRIDLPNEEVKELIRQQNWDSLIAGDQLINQKNAGQVFRGFLEGKVTF
APTYKYDLFSDDYDTSEKCRTPAWTDRVLWRRRKWPFDRSAEDLDLLNASFQDESKILYT
WTPGTLLHYGRAELKTSDHRPVVALIDIDIFEVEAEERQNIYKEVIAVQGPPDGTVLVSI
KSSLPENNFFDDALIDELLQQFASFGEVILIRFVEDKMWVTFLEGSSALNVLSLNGKELL
NRTITIALKSPDWIKNLEEEMSLEKISIALPSSTSSTLLGEDAEVAADFDMEGDVDDYSA
EVEELLPQHLQPSSSSGLGTSPSSSPRTSPCQSPTISEGPVPSLPIRPSRAPSRTPGPPS
AQSSPIDAQPATPLPQKDPAQPLEPKRPPPPRPVAPPTRPAPPQRPPPPSGARSPAPTRK
EFGGIGAPPSPGVARREMEAPKSPGTTRKDNIGRSQPSPQAGLAGPGPAGYSTARPTIPP
RAGVISAPQSHARASAGRLTPESQSKTSETSKGSTFLPEPLKPQAAFPPQSSLPPPAQRL
QEPLVPVAAPMPQSGPQPNLETPPQPPPRSRSSHSLPSEASSQPQVKTNGISDGKRESPL
KIDPFEDLSFNLLAVSKAQLSVQTSPVPTPDPKRLIQLPSATQSNVLSSVSCMPTMPPIP
ARSQSQENMRSSPNPFITGLTRTNPFSDRTAAPGNPFRAKSEESEATSWFSKEEPVTISP
FPSLQPLGHNKSRASSSLDGFKDSFDLQGQSTLKISNPKGWVTFEEEEDFGVKGKSKSAC
SDLLGNQPSSFSGSNLTLNDDWNKGTNVSFCVLPSRRPPPPPVPLLPPGTSPPVDPFTTL
ASKASPTLDFTER
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>